Back
Madrigal Pharmaceuticals Quote, Financials, Valuation and Earnings
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
50
MDGL
Madrigal Pharmaceuticals
Last Price:
242.38
Seasonality Move:
23.49%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Madrigal Pharmaceuticals Price Quote
$242.38
+0.13 (+3.88%)
(Updated: September 20, 2024 at 6:51 AM ET)
Madrigal Pharmaceuticals Key Stats
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Day range:
$233.50 - $248.19
52-week range:
$119.76 - $299.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.14%
Volume:
286.5K
Avg. volume:
223.6K
1-year change:
43.05%
Market cap:
$5.3B
Revenue:
$0
EPS:
$-25.54
How Much Does Madrigal Pharmaceuticals Make?
Data Unavailable
Is Madrigal Pharmaceuticals Growing As A Company?
Data Unavailable
Madrigal Pharmaceuticals Stock Price Performance
-
Did Madrigal Pharmaceuticals Stock Go Up Last Month?
Madrigal Pharmaceuticals share price went down by -5.64% last month -
Did MDGL's Share Price Rise Over The Last Year?
MDGL share price rose by 43.05% over the past 1 year
What Is Madrigal Pharmaceuticals 52-Week High & Low?
-
What Is Madrigal Pharmaceuticals’s 52-Week High Share Price?
Madrigal Pharmaceuticals has traded as high as $299.98 over the past 52 weeks -
What Is Madrigal Pharmaceuticals’s 52-Week Low Share Price?
Madrigal Pharmaceuticals has traded as low as $119.76 over the past 52 weeks
Madrigal Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Madrigal Pharmaceuticals?
-
How Much Debt Does Madrigal Pharmaceuticals Have?
Total long term debt quarterly is $116.6M -
How Much Cash Does Madrigal Pharmaceuticals Have?
Cash and short term investments quarterly total is $1.1B -
What Is Madrigal Pharmaceuticals’s Book Value Per Share?
Book value per share is 39.50
Is Madrigal Pharmaceuticals Cash Flow Positive?
-
What Is MDGL Cash Flow From Operations?
Cash flow from operations (TTM) is -$449M -
What Is Madrigal Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2B -
What Is Madrigal Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$336M
Madrigal Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
MDGL return on invested capital is -91.11% -
What Is Madrigal Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -75.89% -
What Is MDGL Return On Equity?
ROE is a measure of profitability and is -113.99%
Madrigal Pharmaceuticals Earnings Date & Stock Price
-
What Is Madrigal Pharmaceuticals's Stock Price Today?
A single share of MDGL can be purchased today for 242.25 -
What Is Madrigal Pharmaceuticals’s Stock Symbol?
Madrigal Pharmaceuticals trades on the nasdaq under the ticker symbol: MDGL -
When Is Madrigal Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Madrigal Pharmaceuticals is scheduled on November 6, 2024 -
When Is MDGL's next ex-dividend date?
Madrigal Pharmaceuticals's next ex-dividend date is September 20, 2024 -
How To Buy Madrigal Pharmaceuticals Stock?
You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Madrigal Pharmaceuticals Competitors
-
Who Are Madrigal Pharmaceuticals's Competitors?
Below is a list of companies who compete with Madrigal Pharmaceuticals or are related in some way:
Madrigal Pharmaceuticals Dividend Yield
-
What Is MDGL Dividend Yield?
Madrigal Pharmaceuticals’s dividend yield currently is 0% -
What Is Madrigal Pharmaceuticals’s Payout Ratio?
Madrigal Pharmaceuticals’s payout ratio is 0% -
When Did Madrigal Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Madrigal Pharmaceuticals’s Dividend Per Share?
Madrigal Pharmaceuticals pays a dividend of $0.00 per share
Madrigal Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 7.33% |
| Revenue: | 0% | 233.98% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 360.57 |
| Upside from Last Price: | 48.84% |